Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.5B | 2.5B | 2.5B | 2.5B |
Cost of revenue | 1.1B | 1.1B | 1.1B | 1.1B |
Gross profit | 1.4B | 1.4B | 1.4B | 1.4B |
Operating expense | ||||
Research & development | 222M | 232M | 225M | 220M |
Selling general and admin | 813M | 802M | 809M | 837M |
Other operating expenses | -120M | -44M | 5M | -1M |
Operating income | 468M | 395M | 332M | 318M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 49M | 48M | 49M | 50M |
Other income expense | -14M | — | — | — |
Pretax income | 414M | 349M | 292M | 280M |
Tax provision | 64M | 65M | 29M | 57M |
Net income | 350M | 284M | 263M | 223M |
Basic EPS | 0.7 | 0.6 | 0.5 | 0.5 |
Diluted EPS | 0.7 | 0.6 | 0.5 | 0.5 |
Basic average shares | 495.1M | 494.7M | 494.6M | 494.5M |
Diluted average shares | 498M | 498.1M | 497.7M | 497M |
EBITDA | 463M | 397M | 341M | 330M |
Net income from continuing op. | — | — | — | 223M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |